CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

How does it work

CPHI Online is a global marketplace.

The place where global Pharma professionals come to source new partners, look for products and solutions and make connections – all year round. It’s also a go-to place to learn about the latest trends, developments and news in the Pharma industry.

If your company wants to do business with the global Pharma industry, this is the place to be.

Why CPHI Online

CPHI Online is the largest global marketplace where the pharma community comes to source new partners, showcase products and solutions, and make connections.

Direct access to your target Pharma audience
Effective reporting
Multi or single channel campaigns
Measurable communications and results
Scalable multi-channel campaigns
Build brand credibility
Generate leads
Access to expert analysts
Promotional campaign around your content
Innovative and memorable content

Trusted by over 7,000 pharma companies, including:

Top Products

CPHI Pharmaceutical Products, Companies and News

Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights

News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights

The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...

Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...

Protecting life-saving therapies: CPHI Online Podcast Series

News Protecting life-saving therapies: CPHI Online Podcast Series

The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.